Are two cancer immunotherapy drugs better than one?
The difficult search for the right recipe in cancer immunotherapy
A class of immunotherapy drugs called checkpoint inhibitors has shown great promise against cancer in some patients. However, researchers' attempts to boost the drugs' efficacy by combining them with other immunotherapies have been disappointing. An article in Chemical & Engineering News (C&EN), the weekly news magazine of the American Chemical Society, describes the many challenges involved with harnessing the immune system to fight cancer.Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy